Accelerating MedTech Market Entry
Accelerating MedTech Market Entry
Eliomedica Inc is a strategy firm with a focus on medical devices. We specialize in crafting comprehensive market entry strategies, aligning regulatory, development, and business milestones.
Our expertise ensures that your products meet market needs and facilitates successful go-to-market strategies.
Our team blends regulatory, science, and commercialization expertise, excelling in software, hardware, and connected devices, including:
- Point-of-Care & Cloud-Connected Devices
- Electro-Mechanical Systems
- Software-as-a-Medical Device (SaMD)
- Digital Health
Our engagement model provides tailored partnerships, hands on delivery and continuous support toward a successful market entry.
We are dedicated to partnering with startups, spin-offs from large organizations and physician entrepreneurs.
Every innovation and startup is unique. We facilitate startup exit through partnerships, strategic collaborations, and joint ventures.
Founder & Managing Partner
Product Strategy
Highlights:
Business Dev at StarFish Medical
Systems Eng at Synaptive Medical
Partner
Investment & Business Dev
Highlights:
Business Dev at MediPines
Business Dev at Pramptex
Analyst
Translational Research
Highlights:
Co-founder at Specifix
Regulatory at AiimSense
Advisor
Health Data & AI
Highlights:
Head, Ontario Brain Institute
Director, UHN
Senior Advisor
Regulatory & Strategy
Highlights:
SVP, Profound Medical
Founder, MRS and Wisdom Waves
Eliomedica's expertise in regulatory and pre-clinical strategy was invaluable for our MedTech startup, providing the clarity and direction needed to navigate complex compliance landscapes. Their insights significantly enhanced our value proposition, setting a solid foundation for our product development and market entry.
---
We partnered with Eliomedica to collaboratively lay the foundation for a holistic commercialization strategy. The outcome supports our internal alignment and investor communications. Their first-principles and adaptable approach makes them a valuable partner in our journey towards market fit and growth. We found Eliomedica committed to long-term relationships and look forward to ongoing collaboration with them.
Dr Robert Arntfield, MD
CEO, Deep Breathe AI
Discovery Park is one of Canada’s leading science & technology parks and is the catalyst for commercialization, partnership development and research translation.